These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Bringuier PP; Tamimi Y; Schuuring E; Schalken J Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895 [TBL] [Abstract][Full Text] [Related]
3. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415 [TBL] [Abstract][Full Text] [Related]
4. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000 [TBL] [Abstract][Full Text] [Related]
5. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Freier K; Sticht C; Hofele C; Flechtenmacher C; Stange D; Puccio L; Toedt G; Radlwimmer B; Lichter P; Joos S Genes Chromosomes Cancer; 2006 Feb; 45(2):118-25. PubMed ID: 16235239 [TBL] [Abstract][Full Text] [Related]
6. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285 [TBL] [Abstract][Full Text] [Related]
7. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139 [TBL] [Abstract][Full Text] [Related]
8. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors. Yuan B; Oechsli MN; Hendler FJ Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609 [TBL] [Abstract][Full Text] [Related]
9. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244 [TBL] [Abstract][Full Text] [Related]
10. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Huang X; Godfrey TE; Gooding WE; McCarty KS; Gollin SM Genes Chromosomes Cancer; 2006 Nov; 45(11):1058-69. PubMed ID: 16906560 [TBL] [Abstract][Full Text] [Related]
13. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801 [TBL] [Abstract][Full Text] [Related]
14. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. Gaffey MJ; Frierson HF; Williams ME Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628 [TBL] [Abstract][Full Text] [Related]
15. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112 [TBL] [Abstract][Full Text] [Related]
16. PPFIA1 and CCND1 are frequently coamplified in breast cancer. Dancau AM; Wuth L; Waschow M; Holst F; Krohn A; Choschzick M; Terracciano L; Politis S; Kurtz S; Lebeau A; Friedrichs K; Wencke K; Monni O; Simon R Genes Chromosomes Cancer; 2010 Jan; 49(1):1-8. PubMed ID: 19787783 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340 [TBL] [Abstract][Full Text] [Related]
18. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035 [TBL] [Abstract][Full Text] [Related]
19. Comparative genomics on mammalian Fgf3-Fgf4 locus. Katoh M; Katoh M Int J Oncol; 2005 Jul; 27(1):281-5. PubMed ID: 15942670 [TBL] [Abstract][Full Text] [Related]
20. FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the eight-transmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products. Katoh M; Katoh M Int J Oncol; 2003 Jun; 22(6):1375-81. PubMed ID: 12739008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]